Michael Cherny
Stock Analyst at Leerink Partners
(4.08)
# 1,471
Out of 4,556 analysts
552
Total ratings
56.6%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintained: Buy | $38 | $31.35 | +21.21% | 36 | Jul 22, 2026 | |
| ALGN Align Technology | Reiterated: Buy | $230 | $172.46 | +33.36% | 20 | Jun 30, 2026 | |
| CERT Certara | Reiterated: Buy | $13 → $8 | $6.89 | +16.11% | 16 | Jun 16, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Hold | n/a | $13.27 | - | 34 | Jun 12, 2026 | |
| MDLN Medline | Maintained: Buy | $56 → $52 | $37.18 | +39.86% | 4 | Jun 12, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Hold | $125 → $145 | $167.28 | -13.32% | 17 | May 28, 2026 | |
| DOCS Doximity | Rated: Buy | $79 → $25 | $20.49 | +22.01% | 14 | May 15, 2026 | |
| HIMS Hims & Hers Health | Maintained: Hold | n/a | $31.68 | - | 32 | Apr 16, 2026 | |
| CVS CVS Health | Reiterated: Buy | $98 | $108.08 | -9.33% | 66 | Mar 24, 2026 | |
| HSIC Henry Schein | Reiterated: Hold | $87 | $84.81 | +2.58% | 31 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $26.43 | +32.43% | 24 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $20.79 | +106.83% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $187 → $240 | $220.54 | +8.82% | 38 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $232 → $256 | $198.52 | +28.95% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $209.83 | +0.08% | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $6 | $3.16 | +89.87% | 21 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 → $342 | $281.46 | +21.51% | 14 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $455 → $490 | $528.12 | -7.22% | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $349 → $361 | $300.58 | +20.10% | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $814.04 | - | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.93 | - | 23 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $8.92 | -15.92% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $472.57 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $139.64 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.20 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $4.80 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $11.66 | n/a | 1 | Jan 5, 2022 |
Progyny
Jul 22, 2026
Maintained: Buy
Price Target: $38
Current: $31.35
Upside: +21.21%
Align Technology
Jun 30, 2026
Reiterated: Buy
Price Target: $230
Current: $172.46
Upside: +33.36%
Certara
Jun 16, 2026
Reiterated: Buy
Price Target: $13 → $8
Current: $6.89
Upside: +16.11%
DENTSPLY SIRONA
Jun 12, 2026
Maintained: Hold
Price Target: n/a
Current: $13.27
Upside: -
Medline
Jun 12, 2026
Maintained: Buy
Price Target: $56 → $52
Current: $37.18
Upside: +39.86%
ICON Public Limited Company
May 28, 2026
Maintained: Hold
Price Target: $125 → $145
Current: $167.28
Upside: -13.32%
Doximity
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $20.49
Upside: +22.01%
Hims & Hers Health
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $31.68
Upside: -
CVS Health
Mar 24, 2026
Reiterated: Buy
Price Target: $98
Current: $108.08
Upside: -9.33%
Henry Schein
Feb 24, 2026
Reiterated: Hold
Price Target: $87
Current: $84.81
Upside: +2.58%
Feb 6, 2026
Upgraded: Buy
Price Target: $35
Current: $26.43
Upside: +32.43%
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $20.79
Upside: +106.83%
Jan 13, 2026
Reiterated: Buy
Price Target: $187 → $240
Current: $220.54
Upside: +8.82%
Dec 14, 2025
Maintained: Buy
Price Target: $232 → $256
Current: $198.52
Upside: +28.95%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $209.83
Upside: +0.08%
Oct 9, 2025
Rated: Hold
Price Target: $5 → $6
Current: $3.16
Upside: +89.87%
Oct 8, 2025
Reiterated: Buy
Price Target: $323 → $342
Current: $281.46
Upside: +21.51%
Oct 8, 2025
Reiterated: Hold
Price Target: $455 → $490
Current: $528.12
Upside: -7.22%
Oct 6, 2025
Maintained: Buy
Price Target: $349 → $361
Current: $300.58
Upside: +20.10%
Oct 6, 2025
Maintained: Buy
Price Target: n/a
Current: $814.04
Upside: -
Oct 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.93
Upside: -
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $8.92
Upside: -15.92%
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $472.57
Upside: n/a
Sep 4, 2024
Maintained: Hold
Price Target: n/a
Current: $139.64
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.20
Upside: n/a
Jun 14, 2023
Maintained: Buy
Price Target: $22
Current: $4.80
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7.5
Current: $11.66
Upside: n/a